Adherence to a Recommended Exercise Regimen in Colorectal Cancer Patients

Completed · Not applicable

Conditions studied: Colorectal Cancer (CRC)

In brief

Given the apparent effect of 18 metabolic equivalent task-hours of activity/week in improving disease free survival in patients with treated stage 3 colon cancer and the survival benefit of exercise demonstrated in patients with stage II and III colorectal cancer, the primary objective is to evaluate compliance at 6 months with post-treatment recommendations for a minimum of 18 metabolic units of physical activity each week in patients who have completed therapy for stage 2 and stage 3 colorectal cancer.

Key facts

Study ID

NCT00977613

Run by

Beth Israel Medical Center

People needed

50

Starts

2007-04-01

Expected to finish

2010-05-01

Last updated by the study team

2011-03-03

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with histological confirmation of stage 2 or stage 3 colorectal cancer.
• Ability to sign written informed consent.
• WHO performance status of 2 or better.
• No evidence of recurrent disease or death prior to second questionnaire.
• Patients with declining physical activity within 90 days of second physical activity assessment will be excluded.
• There are no exclusion criteria

Where it is running

• Beth Israel Medical Center - Philipps Ambulatory Care Center — New York, New York, United States
• St. Luke's Roosevelt Hospital Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.